The revolutionary technology of the CRISPR/Cas9 system has brought rapid, efficient and precise genome engineering within reach of many researchers.

This webinar focuses on the utilization of CRISPR/Cas9 technology in drug discovery, with an emphasis on generating in vitro models for high-throughput screening and creating new mouse models.

Several CRISPR/Cas9 case studies covering different aspects of the drug discovery process are discussed.


  • Anne-Marie Zuurmond, PhD, Associate Director of Genome Engineering, Charles River